疫情追蹤 | Omicron已波及27個國家和地區
Omicron正以遠高於Delta毒株的速度傳播,自11月25日於南非發現以來,目前已傳染到20多個國家,包括澳大利亞、奧地利、英國、美國、韓國等。南非昨日單日新冠確診病例較週二躍增近一倍,11月新冠樣本中74%發現omicron毒株。
越來越多的國家開始實行旅行限制,拜登的首席醫療顧問安東尼·福奇表示,美國因omicron變異毒株而對非洲南部實施的旅行限制將是臨時性的。
雖然變異毒株omicron的傳染性更強,但初步報告顯示它的致死率可能也更低。歐洲疾病預防控制中心此前表示,目前所有確診病例屬於輕微或無症狀感染。
世界衛生組織的首席科學家表示,新冠疫苗料將防止omicron變異株感染者發展爲重症。Moderna總裁稱,該公司可能最早在明年3月份完成對omicron毒株疫苗加強針的試驗,並準備好申請美國監管當局的授權。

圖片來源:The New York Times
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.